17q25 Locus Is Associated With White Matter Hyperintensity Volume in Ischemic Stroke, But Not With Lacunar Stroke Status
暂无分享,去创建一个
Kaitlin M. Fitzpatrick | C. Sudlow | M. Fornage | K. Furie | B. Psaty | P. Rothwell | E. Parati | M. Dichgans | S. Kittner | J. Wardlaw | J. Bis | E. Holliday | T. Mosley | C. Levi | B. Mitchell | H. Markus | J. Maguire | W. Longstreth | Pankaj Sharma | A. Biffi | N. Rost | K. Fitzpatrick | A. Kanakis | J. Rosand | G. Falcone | C. Leiva-Salinas | R. Malik | Alexa N Richie | K. Wiggins | J. Meschia | A. Gschwendtner | B. Worrall | W. Devan | M. Traylor | S. Bevan | G. Boncoraglio | Valerie Valant | Y. Cheng | S. Lanfranconi | Dale M. Gamble | H. Segal | B. Lau | E. Ciusani | Poneh Adib-Samii | M. Saleem Khan | Yuching Cheng | Yuching Cheng | Yuching Cheng | Allison Kanakis | B. Psaty
[1] C. Gieger,et al. Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke , 2008, Annals of neurology.
[2] P. Donnelly,et al. A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.
[3] K. Jellinger,et al. Heterogeneity in age-related white matter changes , 2011, Acta Neuropathologica.
[4] Benjamin F. J. Verhaaren,et al. Replication Study of Chr17q25 With Cerebral White Matter Lesion Volume , 2011, Stroke.
[5] Daniel B Hier,et al. The Stroke Data Bank: design, methods, and baseline characteristics. , 1988, Stroke.
[6] Fred A. Wright,et al. seeQTL: a searchable database for human eQTLs , 2011, Bioinform..
[7] B. McLaughlin,et al. The ubiquitin-proteasome system as a drug target in cerebrovascular disease: therapeutic potential of proteasome inhibitors. , 2005, Current opinion in investigational drugs.
[8] Scott Silliman,et al. The Ischemic Stroke Genetics Study (ISGS) Protocol , 2003, BMC neurology.
[9] Eric E. Smith,et al. White matter hyperintensity volume is increased in small vessel stroke subtypes , 2010, Neurology.
[10] T. Lumley,et al. Antihypertensive treatment with ACE inhibitors or beta-blockers and risk of incident atrial fibrillation in a general hypertensive population. , 2009, American journal of hypertension.
[11] I. Deary,et al. Failure to validate association between 12p13 variants and ischemic stroke , 2010 .
[12] D. Hernandez,et al. Siblings With Ischemic Stroke Study: Results of a Genome-Wide Scan for Stroke Loci , 2011, Stroke.
[13] Yurii S. Aulchenko,et al. ProbABEL package for genome-wide association analysis of imputed data , 2010, BMC Bioinformatics.
[14] A. Folsom,et al. Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. , 1999, Stroke.
[15] P. Froguel,et al. Bio-Repository of DNA in stroke (BRAINS): A study protocol , 2011, BMC Medical Genetics.
[16] D. Koller,et al. Population genomics of human gene expression , 2007, Nature Genetics.
[17] Eric E. Smith,et al. Validation of Intracranial Area as a Surrogate Measure of Intracranial Volume When Using Clinical MRI , 2007, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[18] G. Meroni,et al. TRIM/RBCC, a novel class of ‘single protein RING finger’ E3 ubiquitin ligases , 2005, BioEssays : news and reviews in molecular, cellular and developmental biology.
[19] P. Koudstaal,et al. Silent brain infarcts: a systematic review , 2007, The Lancet Neurology.
[20] D. Strachan,et al. Genetic variation associated with plasma von Willebrand factor levels and the risk of incident venous thrombosis. , 2011, Blood.
[21] R. Kronmal,et al. The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.
[22] M. Pirinen,et al. Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke , 2012, Nature Genetics.
[23] Yurii S. Aulchenko,et al. BIOINFORMATICS APPLICATIONS NOTE doi:10.1093/bioinformatics/btm108 Genetics and population analysis GenABEL: an R library for genome-wide association analysis , 2022 .
[24] G. Barker,et al. Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques. , 1996, Magnetic resonance imaging.
[25] M. Fornage,et al. Genome‐wide association studies of cerebral white matter lesion burden , 2011, Annals of neurology.
[26] J. Duke,et al. Cohort profile: The Hunter Community Study. , 2010, International journal of epidemiology.
[27] David Lee Gordon,et al. Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.
[28] Yun Li,et al. METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..
[29] K. Furie,et al. An evidence‐based causative classification system for acute ischemic stroke , 2005, Annals of neurology.
[30] C. Sudlow,et al. Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE Collaboration): a meta-analysis of genome-wide association studies , 2012, The Lancet Neurology.
[31] A. Folsom,et al. Postural Changes in Blood Pressure and Incidence of Ischemic Stroke Subtypes: The ARIC Study , 2011, Hypertension.
[32] J. O'Brien,et al. Microarray RNA Expression Analysis of Cerebral White Matter Lesions Reveals Changes in Multiple Functional Pathways , 2009, Stroke.
[33] H. Markus,et al. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis , 2010, BMJ : British Medical Journal.
[34] Stephen M. Smith,et al. Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.
[35] Anders M. Dale,et al. MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: Reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths , 2009, NeuroImage.